Positive Media Coverage Somewhat Unlikely to Affect Universal Health Realty Income Trust (UHT) Share Price
News headlines about Universal Health Realty Income Trust (NYSE:UHT) have been trending positive on Friday, Accern reports. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Universal Health Realty Income Trust earned a coverage optimism score of 0.45 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 48.0294313088895 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Separately, BidaskClub downgraded shares of Universal Health Realty Income Trust from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th.
Shares of Universal Health Realty Income Trust (NYSE UHT) traded up $1.11 on Friday, reaching $73.25. 44,000 shares of the company traded hands, compared to its average volume of 47,709. Universal Health Realty Income Trust has a 1 year low of $54.83 and a 1 year high of $84.90. The stock has a market cap of $990.82, a P/E ratio of 22.98 and a beta of 0.35. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.01 and a current ratio of 1.01.
Universal Health Realty Income Trust Company Profile
Universal Health Realty Income Trust is a real estate investment trust (REIT). The Company invests in healthcare and human service related facilities, including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings (MOBs).
Receive News & Stock Ratings for Universal Health Realty Income Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Realty Income Trust and related stocks with our FREE daily email newsletter.